Entrectinib
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Entrectinib, covering 2020-01-27 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors [Phase 2]